T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fidelity National Information Services
FIS
$22.8B
| $446M | 0.1% |
6,654,178
-3,493,241
| -34% | -$233M |
|
227
Amgen
AMGN
$226B
| $445M | 0.1% |
3,214,341
-1,141,646
| -26% | -$180M |
|
|
CTLT
228
DELISTED
CATALENT, INC.
CTLT
| $443M | 0.1% |
18,226,778
+473,570
| +3% | +$14.4M |
|
229
Emerson Electric
EMR
$91.6B
| $440M | 0.1% |
9,961,191
+51,530
| +0.5% | +$2.53M |
|
230
Public Storage
PSA
$61.4B
| $439M | 0.1% |
2,076,431
-43,478
| -2% | -$8.86M |
|
|
RDS.B
231
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $436M | 0.1% |
9,182,802
+96,141
| +1% | +$5.18M |
|
232
Ball Corp
BALL
$16.4B
| $436M | 0.1% |
14,015,276
+2,084,164
| +17% | +$70.6M |
|
233
Sysco
SYY
$40B
| $436M | 0.1% |
11,179,277
-3,846,433
| -26% | -$147M |
|
234
Stryker
SYK
$131B
| $433M | 0.1% |
4,597,223
+486,737
| +12% | +$48.2M |
|
235
Nucor
NUE
$61.8B
| $431M | 0.1% |
11,472,958
+585,924
| +5% | +$25.1M |
|
236
West Pharmaceutical
WST
$24.4B
| $429M | 0.1% |
7,934,755
+1,424,259
| +22% | +$83M |
|
237
Pediatrix Medical
MD
$2.14B
| $429M | 0.1% |
5,581,246
+36,480
| +0.7% | +$2.94M |
|
238
Xylem
XYL
$28.1B
| $427M | 0.1% |
12,998,805
-4,574,889
| -26% | -$154M |
|
239
Choice Hotels
CHH
$4.71B
| $427M | 0.09% |
8,951,233
+96,121
| +1% | +$4.92M |
|
240
Ingredion
INGR
$6.63B
| $425M | 0.09% |
4,870,001
+156,404
| +3% | +$13.4M |
|
241
L3Harris
LHX
$53.7B
| $424M | 0.09% |
5,800,219
-405,266
| -7% | -$31.7M |
|
242
Universal Health Services
UHS
$10.1B
| $423M | 0.09% |
3,386,484
-41,489
| -1% | -$5.77M |
|
243
JD.com
JD
$39.6B
| $421M | 0.09% |
16,159,113
-598,191
| -4% | -$17.3M |
|
|
GGP
244
DELISTED
GGP Inc.
GGP
| $410M | 0.09% |
15,782,671
+155,492
| +1% | +$4.09M |
|
|
WCG
245
DELISTED
Wellcare Health Plans, Inc.
WCG
| $408M | 0.09% |
4,738,449
-231,713
| -5% | -$20.3M |
|
246
General Motors
GM
$75.8B
| $406M | 0.09% |
13,537,160
-6,278
| -0% | -$192K |
|
|
ALTR
247
DELISTED
Altera Corp
ALTR
| $406M | 0.09% |
8,099,208
-10,331,890
| -56% | -$514M |
|
248
RH
RH
$3.4B
| $405M | 0.09% |
4,345,058
+267,267
| +7% | +$26.3M |
|
249
Digital Realty Trust
DLR
$73.1B
| $403M | 0.09% |
6,168,783
+24,480
| +0.4% | +$1.6M |
|
250
Cardinal Health
CAH
$53.8B
| $402M | 0.09% |
5,233,839
+596,773
| +13% | +$49.9M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.